- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04210648
Effectiveness and Security Testing of a Mobile App for Self-Managing Emotion Dysregulation
September 12, 2024 updated by: Consorci Sanitari del Maresme
Effectiveness and Security Testing of a Mobile App for Self-Managing Emotion Dysregulation in a Non-Clinical Population With Borderline Traits: A Randomized Controlled Trial
To assess the effectiveness and security of a mobile App (beta version) for people with borderline traits recruited from a non-clinical population of college students in Barcelona (Spain).
The main primary outcome will be the severity of the emotional dysregulation.
Forty participants will use the mobile app over 6 months.
This group while be compared at post-treatment and at 3-month follow-up with other 40 participants (control group) with any intervention.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alvaro Frias
- Phone Number: 0034689554606
- Email: afrias@csdm.cat
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Borderline traits
- Aged between 18 to 65 years
- College students
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Those who will use the mobile app
|
Mobile app for self-managing emotional dysregulation
|
|
No Intervention: Non-intervention group
Those who will not use the mobile app
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotion dysregulation severity
Time Frame: 9-month
|
Severity of emotional dysregulation as measured by a single score from the The DERS scale (Difficulties in Emotion Regulation scale) (range: 0-88; the higher the score, the more severe the emotion dysregulation severity).
|
9-month
|
|
smartphone addiction
Time Frame: 9-month
|
Severity of smartphone addiction as measured by the Spanish version of the The Smartphone Addiction Scale (SAS) (range: 10-60; the higher the score, the more severe the smartphone addiction severity).
|
9-month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
October 1, 2028
Study Registration Dates
First Submitted
December 19, 2019
First Submitted That Met QC Criteria
December 23, 2019
First Posted (Actual)
December 26, 2019
Study Record Updates
Last Update Posted (Actual)
September 19, 2024
Last Update Submitted That Met QC Criteria
September 12, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 32-16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emotional Dysregulation
-
Northwestern UniversityCompletedEmotional DysregulationUnited States
-
Neuromotion LabsNational Institute of Mental Health (NIMH); Magellan HealthcareCompleted
-
Karolinska InstitutetCompletedEmotional DysregulationSweden
-
Massachusetts General HospitalMassachusetts Institute of TechnologyNot yet recruitingEmotional DysregulationUnited States
-
Soroka University Medical CenterUnknownEmotional Dysregulation | Dialectical Behavioral TherapyIsrael
-
University Hospital, Strasbourg, FranceNot yet recruitingEmotional Dysregulation | Addiction DisordersFrance
-
Fundación Pública Andaluza para la gestión de la...Instituto de Salud Carlos III; Hospital Universitario Virgen del RocioNot yet recruitingNeurodevelopmental Disorders | Irritability | Distress, Emotional | Emotional Dysregulation | Impulsivity | Distress, PsychologicalSpain
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompletedEmotional DysregulationItaly
-
University of Texas Southwestern Medical CenterNot yet recruitingAdolescent | Depression | Emotional Dysregulation | Family Relationship | HRVUnited States
-
Oslo University HospitalNorwegian Academy of MusicRecruitingDepressive Disorder | Emotional DysregulationNorway
Clinical Trials on Mobile app
-
Pamela HullUnited States Department of Agriculture (USDA)RecruitingObesity, Childhood | Physical Inactivity | Nutrition, Healthy | Sleep, InadequateUnited States
-
The University of Hong KongNorth District Hospital; Queen Mary Hospital, Hong Kong; Pamela Youde Nethersole... and other collaboratorsUnknownSelf Inflicted Injury | Suicide and Self Inflicted InjuryHong Kong
-
University of ValenciaMinistry of Science and InnovationCompleted
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical CenterCompletedPost Traumatic Stress DisorderUnited States
-
Tan Tock Seng HospitalNanyang Technological University; Geriatric Education and Research InstituteEnrolling by invitationCognitive DeclineSingapore
-
Duke UniversityDuke Institute for Health InnovationCompleted
-
Weill Medical College of Cornell UniversityChildren's Health FundRecruitingDepression | Bipolar Disorder | Anxiety Disorders and Symptoms | SymptomsUnited States
-
Arizona State UniversityThe University of Texas Health Science Center at San AntonioCompleted
-
University of ZurichSwitzerland: ETH; Switzerland: MakoraCompleted
-
Aarhus University HospitalRecruitingTic DisordersDenmark